Type 2 neurofibromatosis: the need for supraregional care?
The results of a U.K. study of 145 cases of type 2 neurofibromatosis has shown generally very poor operative results in terms of hearing and facial nerve preservation. Only 9 out of 118 vestibular schwannoma (acoustic neuroma) operations resulted in any clinically detectable hearing preservation and only 32 left the patient with good or normal (House grade I or II) ipsilateral facial nerve function. Although operation is still the definitive treatment of vestibular schwannoma (acoustic neuroma) and may be a lifesaving procedure, it appears that the evidence in favour of early operation is only valid when carried out in highly specialized centres. The special problems of NF2 cases who may go on to develop multiple spinal and cranial tumours making them wheelchair bound and blind as well as deaf warrants a careful experienced approach. Timing of operations may be critical for the enhancement of useful years of quality life. We therefore propose the setting up of a national NF2 register, with the management of cases at a few supraregional centres.
Evans
D G
DG
Department of Medical Genetics, St Mary's Hospital, Manchester.
Ramsden
R
R
Huson
S M
SM
Harris
R
R
Lye
R
R
King
T T
TT
D000328:Adult; D004739:England / Q000453:epidemiology; D005190:Family; D006801:Humans; D016518:Neurofibromatosis 2 / Q000453:epidemiology / Q000235:genetics / Q000601:surgery*; D012041:Regional Medical Programs / Q000458:organization & administration; D012042:Registries; D016896:Treatment Outcome